Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device Business Strategies Advertising, Marketing & Sales

Biomet Cites Q4 Sales Boost From JuggerKnot Sports Med Implants

This article was originally published in The Gray Sheet

  • News

Executive Summary

The company’s sports, extremities and trauma products generated 14% growth last quarter with the help of its JuggerKnot Soft Anchor sports medicine products.

You may also be interested in...



Johnson & Johnson CEO Gorsky Reaffirms Diversified Strategy

Faced with spin-off models from other diversified health care firms, including Abbott and Pfizer, Gorsky defended J&J’s broader-based approach as a better long-term strategy.

Biomet Offers $280 Mil. For J&J’s DePuy Trauma Biz; Bid Facilitates Synthes Deal

J&J expects the divestiture to reduce regulatory barriers to its pending $21 billion Synthes acquisition.

People In Brief

The latest moves by movers and shakers in the medical device and diagnostics industries.

Table

View full table

Topics

Related Companies

Tags:
Medical Device Business Strategies Advertising, Marketing & Sales
Latest Headlines

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win

See All
UsernamePublicRestriction

Register

MT031402

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By